Archives of internal medicine. 2007;167:2226 32. CLINICAL STATEMENTS AND GUIDELINES Appendix 1. Author Relationships With Industry and Other Entities (Relevant) 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death (October 2017) Committee Member Employment Consultant Speakers Bureau Ownership/ Partnership/ Principal Personal Research Institutional, Organizational, or Other Financial Benefit Expert Witness Voting Recusals by Section* Sana M. Al-Khatib, Chair Duke Clinical Research Institute; Duke University Professor of Medicine None None None None None None None William G. Stevenson, Vice Chair Vanderbilt University Medical Center Professor; Brigham and Women s Hospital Director of Clinical Cardiac EP St. Jude Medical Boston Scientific Biosense Webster Michael J. Ackerman Mayo Clinic Professor of Medicine, Pediatrics, and Pharmacology; Long QT Syndrome/Genetic Heart Rhythm Clinic and the Mayo Clinic Windland Smith Rice Sudden Death Genomics Laboratory Director Audentes Therapeutics Boston Scientific Gilead Sciences Invitae Medtronic MyoKardia St. Jude Medical None None None Transgenomic (Familion) Blue Ox Health Corporation AliveCor StemoniX William J. Bryant Dominick Feld Hyde Attorney at Law None None None None None None None David J. Callans University of Pennsylvania Health System Professor of Medicine; Associate Director of EP Biosense Webster Biotronik Boston Scientific Medtronic St. Jude Medical None None Biosense Webster (PI) Endosense (PI) Anne B. Curtis University at Buffalo SUNY Distinguished Professor; Charles and Mary Bauer Professor and Chair Medtronic St. Jude Medical Barbara J. 